COMPARISON OF SWITCHING TO REDUCED DOSE VS CONTINUATION OF STANDARD DOSE ETANERCEPT FOR RHEUMATOID ARTHRITIS PATIENTS IN THE CORRONA REGISTRY

被引：2
|
作者：
Greenberg, J. D. [1 ,2 ]
Shan, Y. [2 ]
Reed, G. W. [2 ,3 ]
Bitman, B. [4 ]
Collier, D. [5 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] CORRONA Inc, Southborough, MA USA
[3] Univ Massachusetts, Sch Med, Worcestesr, MA USA
[4] Amgen Inc, San Francisco, CA USA
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0174
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [11] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Dimitrios A. Pappas
    Taylor Blachley
    Steve Zlotnick
    Jennie Best
    Kelechi Emeanuru
    Joel M. Kremer
    Rheumatology and Therapy, 2020, 7 : 357 - 369
  • [12] Persistence in Low Disease Activity or Remission with Etanercept Monotherapy in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    Shan, Ying
    Lesperance, Tamara
    Rebello, Sabrina
    Karis, Elaine
    Kricorian, Greg
    Hua, Winnie
    Accortt, Neil A.
    Stryker, Scott
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [13] METHOTREXATE DISCONTINUATION AND DOSE DECREASES AFTER THERAPY WITH TOCILIZUMAB: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie H.
    Emeanuru, Kelechi
    Kremer, Joel
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1150 - 1150
  • [14] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 357 - 369
  • [15] Methotrexate Discontinuation and Dose Decreases After Therapy with Tocilizumab: Results from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [16] Effects of low-dose etanercept in maintaining DAS-remission previously achieved with standard-dose in patients with rheumatoid arthritis
    Botsios, C.
    Furlan, A.
    Ostuni, R.
    Sfriso, R.
    Todesco, S.
    Punzi, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 54 - 54
  • [17] COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB
    Garces, K.
    Thorne, C.
    Boire, G.
    Chow, A.
    Poulin-Costello, M.
    Walker, V
    Haraoui, B.
    VALUE IN HEALTH, 2016, 19 (03) : A229 - A230
  • [18] Clinical and economic efficiency to reduce dose etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 10 (Suppl 3)
  • [19] The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
    Fangfang Chen
    Yitian Lang
    Shikai Geng
    Xiaodong Wang
    Liangjing Lu
    Shuang Ye
    Le Zhang
    Ting Li
    Clinical Rheumatology, 2023, 42 : 2777 - 2786
  • [20] ETANERCEPT DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS - A PILOT STUDY IN SOUTH WALES
    Duffill, S.
    Kia, S.
    Amos, N.
    Thomas, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 500 - 500
12345